NCT06879353 Comparison of Single-Dose Tranexamic Acid Vs. Placebo in Ovarian Cancer Surgery Status COMPLETED Phase NA
NCT06873555 A Study of DC05F01 in Chinese Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06871787 Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology Surgery Status NOT_YET_RECRUITING Phase PHASE4
NCT06855069 HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer Status RECRUITING Phase PHASE3
NCT06853730 Regional Distribution Mapping of Lymph Node Metastasis in Epithelial Ovarian Cancer Status COMPLETED Phase N/A
NCT06851429 Ovarian Cancer Identification on CT Using Deep Learning Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06846424 SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer Status NOT_YET_RECRUITING Phase PHASE1
NCT06846099 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903 Status COMPLETED Phase PHASE1
NCT06844136 ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients Status RECRUITING Phase N/A
NCT06843629 Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors Status RECRUITING Phase N/A
NCT06840002 A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06839144 Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression Status RECRUITING Phase PHASE2
NCT06836219 Measure of Outcomes in Patients With Advanced Ovarian Cancer According to Homologous Recombination Status and Matched Therapies in a Real-world Scenario Status RECRUITING Phase N/A
NCT06824467 A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103) Status RECRUITING Phase PHASE3
NCT06819007 Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) Status RECRUITING Phase PHASE3
NCT06815497 Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer Status RECRUITING Phase PHASE2